- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 171
Lilium levels up latest round to $275m
The air taxi developer added $35m from Baillie Gifford to a $240m first close led by Tencent in March, and is now valued above $1bn.
Jun 9, 2020Unacademy accelerates towards series F
Tencent is among the possible participants in a round that could reportedly double the online learning service provider's $510m valuation.
Jun 8, 2020Tiki ticks $130m funding box
Private equity group Northstar has reportedly led a $130m round for the e-commerce marketplace, which counts JD.com, Sumitomo, CyberAgent and VNG as investors.
Jun 5, 2020Varo arrows to $241m series D
Progressive Insurance has invested in Varo Money as the latter prepares to become the first digital bank to be awarded a national bank charter.
Jun 4, 2020ViaCyte stabilises series D at $107m
The diabetes treatment developer, which counts WL Gore and Johnson & Johnson as investors, has raised a further $27m for its latest round.
May 29, 2020Marqeta makes off with $150m
An undisclosed investor provided the funding at a $4.3bn valuation, Marqeta having previously raised nearly $370m from backers including Commerzbank, Visa and CreditEase.
May 29, 2020Pie Insurance picks out $127m
Existing investor Sirius was among the investors as the worker's compensation provider received a total of $127m, with $100m allocated to the launch of an affiliate called Pie Carrier.
May 29, 2020AbCellera accelerates with $105m
University of Minnesota has invested in UBC spinout AbCellera's series B round that also included Eli Lilly.
May 28, 2020SpaceX rockets to $346m
The Alphabet-backed spacecraft provider has shot past its $250m target to raise $346m in a round expected to value it at $36bn.
May 28, 2020AbCellera accelerates with $105m
Eli Lilly invested in AbCellera's series B round shortly after agreeing a research and collaboration licensing deal with the drug discovery technology provider.
May 28, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


